Stem-Cell liver machine tested in 12 patients

NCT ID NCT07312864

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial is testing a new bioartificial liver device that uses liver cells grown from stem cells. It will be given to 12 people with liver failure or small-for-size syndrome. The main goal is to see if the treatment is safe and tolerable, while also checking for any signs that it might help liver function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bioartificial liver device containing stem-cell-derived liver cells
What this could lead to
If it works, this could provide a temporary liver support system for patients with liver failure, potentially reducing the need for urgent transplantation.
What could go wrong
This is a very early, small trial (12 participants) focused on safety. The treatment may not improve liver function, and there are risks of allergic reactions, infection, or blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Friendship Hospital

    RECRUITING

    Beijing, 101102, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.